Back to Journals » Clinical Interventions in Aging » Volume 11

Multiple myeloma in the very elderly patient: challenges and solutions

Authors Willan J, Eyre TA, Sharpley F, Watson C, King AJ, Ramasamy K

Received 16 December 2015

Accepted for publication 3 February 2016

Published 15 April 2016 Volume 2016:11 Pages 423—435

DOI https://doi.org/10.2147/CIA.S89465

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Lucy Goodman

Peer reviewer comments 2

Editor who approved publication: Dr Richard Walker

John Willan,1 Toby A Eyre,1,2 Faye Sharpley,1 Caroline Watson,1 Andrew J King,1,3 Karthik Ramasamy1,4

1Department of Hematology, 2Early Phase Clinical Trial Unit, Oxford University Hospitals National Health Service (NHS) Foundation Trust, Churchill Hospital, Oxford, UK; 3Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK; 4National Institute for Health Research (NIHR) Biomedical Research Center Blood Theme, Oxford, UK

Abstract: Diagnosis and management of myeloma in the very elderly patient is challenging. Treatment options have vastly improved for elderly myeloma patients but still require the clinician to personalize therapy. In this paper, we offer evidence-based, pragmatic advice on how to overcome six of the main challenges likely to arise: 1) diagnosis of myeloma in this age group, 2) assessment of the need for treatment, and the fitness for combination chemotherapy, 3) provision of the best quality of supportive care, 4) choice of combination chemotherapy in those fit enough for it, 5) treatment of relapsed myeloma, and 6) provision of end of life care. With an increased burden of comorbidities and a reduced resilience to treatment and its associated toxicities, the management of myeloma in this age group requires a different approach to that in younger patients to maximize both quality and length of life.

Keywords: myeloma, elderly, diagnosis, treatment 

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

Evaluation of serum lipid profile, body mass index, and waistline in Chinese patients with type 2 diabetes mellitus

Cui RT, Qi ZM, Zhou L, Li ZH, Li Q, Zhang JY

Clinical Interventions in Aging 2016, 11:445-452

Published Date: 18 April 2016

Effects of teneligliptin on PDMPs and PAI-1 in patients with diabetes on hemodialysis

Okuda Y, Omoto S, Taniura T, Shouzu A, Nomura S

International Journal of General Medicine 2016, 9:65-71

Published Date: 12 April 2016

Height and sex is strongly associated with radial augmentation index in Korean patients with never-treated hypertension

Ahn KT, Park KI, Kim MJ, Oh JK, Han JH, Kwon HJ, Jin SA, Kim JH, Park JH, Lee JH, Choi SW, Seong IW, Jeong JO

Clinical Interventions in Aging 2016, 11:415-422

Published Date: 11 April 2016

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

A novel preparation method for silicone oil nanoemulsions and its application for coating hair with silicone

Hu Z, Liao M, Chen Y, Cai Y, Meng L, Liu Y, Lv N, Liu Z, Yuan W

International Journal of Nanomedicine 2012, 7:5719-5724

Published Date: 12 November 2012